HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

453.486

-12.837-2.75%

Number of Gainers:8

Number of Losers:38

Number of Flat:5

PE:- -

High:466.335

Open:466.335

Low:452.923

Close:466.322

Volume:443.82M

Turnover:11.07B

Market Cap:2.87T

Float Cap:1.99T

Loading ...

Shandong Boan Biotech Confirms RMB 75 Million Finance Lease Asset Sale Price in Supplemental Pact

Everest Medicines Unit Enters Supply, Distribution Cooperation Contract

MT Newswires Live

SUNAC SERVICES Spends Nearly HK$164,000 to Buy Back 200,000 Shares

Sunac Services Files HKEX Next-Day Return Disclosing Share Buyback for Cancellation

Everest Medicines Forms Strategic Alliance with Hissen for China Market Expansion

JXR Allocates HK$2.99 Million to Buy Back 1.35 Million Shares

HBM Holdings' Strategic Partner Secures $225M Series A, Launches Operations

HBM Partner Solstice Oncology Launches Phase 2 Trial of Porustobart in Neoadjuvant MSS Stage II-III Colon Cancer

Harbour Biomed Partner, Solstice Oncology, Announces $225 Million Series a Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy

THOMSON REUTERS

Hbm Holdings - Solstice Oncology Launches $225 Mln Series a Financing Round

THOMSON REUTERS

Shandong Boan Biotech Files HKEX Next-Day Disclosure Return on Share Buyback Cancellation

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Repurchase Cancellation at HKD 20.82-21.38

Jinxin Fertility Files HKEX Next-Day Disclosure Return on Share Buyback at HKD 2.21 Each

Simcere Pharma (02096) Allocates HK$10.70 Million to Buy Back 929,000 Shares on September 9

Simcere Pharmaceutical Files HKEX Next-Day Return Disclosing Share Repurchase for Cancellation

Haidilao's Stock Plunge Masks a More Alarming Number Hidden in Its Half-Year Report

Spousal Stock Moves Raise Questions as Hotpot Giant's Shares Plunge

Ming Yuan Cloud Files HKEX Next-Day Disclosure Return on Share Repurchase for Cancellation

HAIDILAO's Controlling Shareholder Plans to Offload 259 Million Shares via Block Trade

Haidilao Controlling Shareholder S&P NP Sells 259,000,000 Shares in Hk$10.62 Block Trade, Stake Falls to 45.49%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/BK1583/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":453.48572,"timestamp":1789027721934,"preClose":466.32224,"halted":0,"volume":443821561,"delay":0,"changeRate":-0.027527,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-12.836517,"latestTime":"09-10 16:00:00","open":466.33533,"high":466.33533,"low":452.92303,"amount":11066675235.5,"amplitude":0.028762,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"pbRate":2.107662,"peRate":44.521524,"turnoverRate":0.004109,"increases":8,"decrements":39,"flats":2,"marketCap":2868178326048,"floatMarketCap":1992251859328},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":466.33533,"amplitude":0.028762,"preClose":466.32224,"low":452.92303,"pbRate":"2.107662","latestPrice":453.48572,"volume":443821561,"delay":0,"open":466.33533,"prevYearClose":503.90085,"prevWeekClose":481.394,"prevMonthClose":473.951,"prevQuarterClose":402.118,"fiveDayClose":475.543,"twentyDayClose":491.855,"sixtyDayClose":412.026,"secType":"PLATE","market":"HK","turnoverRate":0.004109,"peRate":44.521524,"marketCap":2868178326048,"floatMarketCap":1992251859328,"timestamp":1789027721934,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":8,"down":38,"flat":5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666535062","title":"Shandong Boan Biotech Confirms RMB 75 Million Finance Lease Asset Sale Price in Supplemental Pact","url":"https://stock-news.laohu8.com/highlight/detail?id=2666535062","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666535062?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:31","pubTimestamp":1788960667,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotech confirms RMB 75 million finance lease asset sale price in supplemental pactShandong Boan Biotechnology signed a supplemental agreement on Sep. 9, 2026 for its finance lease with ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDLsF4wJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","LU0572939691.SGD","LU0821914370.USD","LU0264606111.USD","BK1191","BK1161","BK0015","HK0000181112.HKD","LU0572940350.SGD","BK0278","BK0012","BK0187","LU1048596156.SGD","601166","06955","LU1580142542.USD","BK0188","LU1781817850.SGD","BK0028","BK1606","02186","LU1328615791.USD","HK0000181138.USD","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666535781","title":"Everest Medicines Unit Enters Supply, Distribution Cooperation Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2666535781","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666535781?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:26","pubTimestamp":1788960412,"startTime":"0","endTime":"0","summary":"Everest Medicines (HKG:1952) unit Everest Medicines (China) entered into a strategic cooperation framework agreement with Hasten Biopharmaceutical.The contract is for the supply, distribution, and rel","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","BK1574","MDCO","01952","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181637025","title":"SUNAC SERVICES Spends Nearly HK$164,000 to Buy Back 200,000 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1181637025","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181637025?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:41","pubTimestamp":1788957664,"startTime":"0","endTime":"0","summary":"SUNAC SERVICES (01516) has announced that on September 9, 2026, it utilised approximately HK$163,900 to repurchase 200,000 of its own shares.The buyback reflects the company's ongoing capital management strategy in the current market environment.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1229","BK1585","01516","BK1258","BK1583","BK1542"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666533521","title":"Sunac Services Files HKEX Next-Day Return Disclosing Share Buyback for Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666533521","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666533521?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:36","pubTimestamp":1788957409,"startTime":"0","endTime":"0","summary":"Sunac Services files HKEX next-day return disclosing share buyback for cancellationSunac Services filed a next-day disclosure return reporting an on-market repurchase of 200,000 shares on Sept. 9.Repu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDLLwsnr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01516","BK1585","BK1521","BK1258","BK1229","BK1240","BK1555","BK1583","01918","BK1542"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113083232","title":"Everest Medicines Forms Strategic Alliance with Hissen for China Market Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1113083232","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113083232?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:18","pubTimestamp":1788956296,"startTime":"0","endTime":"0","summary":"Everest Medicines (01952) has announced the signing of a strategic cooperation framework agreement with Hissen on September 9, 2026, under which both parties have agreed to establish a framework for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","BK1574","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152232199","title":"JXR Allocates HK$2.99 Million to Buy Back 1.35 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1152232199","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152232199?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:50","pubTimestamp":1788954639,"startTime":"0","endTime":"0","summary":"On September 9, 2026, JXR (01951.HK) executed a share repurchase, investing HK$2.9931 million to acquire 1.3515 million of its own shares.The buyback was conducted at a price range of HK$2.2 to HK$2.25 per share, as disclosed in the company's official announcement.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1597","BK1219","01951","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173908290","title":"HBM Holdings' Strategic Partner Secures $225M Series A, Launches Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=1173908290","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173908290?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:18","pubTimestamp":1788952700,"startTime":"0","endTime":"0","summary":"HBM Holdings (02142) has announced that its partner company Solstice Oncology (Solstice) has successfully completed a $225 million Series A funding round and officially commenced operations. The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142","BK1161","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587460","title":"HBM Partner Solstice Oncology Launches Phase 2 Trial of Porustobart in Neoadjuvant MSS Stage II-III Colon Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587460","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587460?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:15","pubTimestamp":1788952514,"startTime":"0","endTime":"0","summary":"HBM partner Solstice Oncology launches Phase 2 trial of porustobart in neoadjuvant MSS stage II-III colon cancerHBM Holdings’ partner Solstice Oncology launched with a USD 225 million Series A to adva","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL71K3Mm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142","BK1161","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666163587","title":"Harbour Biomed Partner, Solstice Oncology, Announces $225 Million Series a Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2666163587","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666163587?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:12","pubTimestamp":1788952368,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUAC6DRXB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02142","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666976587","title":"Hbm Holdings - Solstice Oncology Launches $225 Mln Series a Financing Round","url":"https://stock-news.laohu8.com/highlight/detail?id=2666976587","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666976587?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:10","pubTimestamp":1788952256,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN4510F0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02142","BK1574","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666458763","title":"Shandong Boan Biotech Files HKEX Next-Day Disclosure Return on Share Buyback Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666458763","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666458763?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:06","pubTimestamp":1788952016,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotech files HKEX next-day disclosure return on share buyback cancellationShandong Boan Biotechnology repurchased 1,000,000 H shares on Sept. 9, 2026, holding them as treasury shares.Bu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL16X2rf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1606","BK1161","BK1191","02186","06955"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666582914","title":"Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Repurchase Cancellation at HKD 20.82-21.38","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582914","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582914?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:45","pubTimestamp":1788950714,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge files HKEX next-day disclosure return on share repurchase cancellation at HKD 20.82-21.38Zylox-Tonbridge filed a next-day disclosure return reporting an on-market buyback of 53,500 H s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL3Z32VH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1100","BK1583","02190","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666828105","title":"Jinxin Fertility Files HKEX Next-Day Disclosure Return on Share Buyback at HKD 2.21 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2666828105","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666828105?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:33","pubTimestamp":1788949987,"startTime":"0","endTime":"0","summary":"Jinxin Fertility files HKEX next-day disclosure return on share buyback at HKD 2.21 eachJinxin Fertility repurchased 1,351,500 shares on Sept. 9, holding them as treasury shares.Buyback price range HK","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL9MFZr6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1219","BK1583","BK1597","01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136349880","title":"Simcere Pharma (02096) Allocates HK$10.70 Million to Buy Back 929,000 Shares on September 9","url":"https://stock-news.laohu8.com/highlight/detail?id=1136349880","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136349880?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:18","pubTimestamp":1788949090,"startTime":"0","endTime":"0","summary":"Simcere Pharma (02096) has disclosed that it spent approximately HK$10.70 million to repurchase 929,000 shares on September 9.According to a company announcement, the share buyback was executed at a total cost of HK$10.7033 million on that date.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1583","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584926","title":"Simcere Pharmaceutical Files HKEX Next-Day Return Disclosing Share Repurchase for Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584926","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584926?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:16","pubTimestamp":1788948983,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical files HKEX next-day return disclosing share repurchase for cancellationSimcere Pharmaceutical repurchased 929,000 ordinary shares for cancellation on Sept. 9 at HKD 11.48–HKD 11","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL3MM0tq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151058847","title":"Haidilao's Stock Plunge Masks a More Alarming Number Hidden in Its Half-Year Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1151058847","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151058847?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:10","pubTimestamp":1788948639,"startTime":"0","endTime":"0","summary":"Haidilao shares suffered a dramatic collapse today, plunging more than 12% at one point to hit a low of HK$10, marking the weakest level since August 2024. The stock has now fallen over 20% so far...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1604","06862","BK1233","BK1591","BK1583","LU2488822045.USD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137756591","title":"Spousal Stock Moves Raise Questions as Hotpot Giant's Shares Plunge","url":"https://stock-news.laohu8.com/highlight/detail?id=1137756591","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137756591?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:10","pubTimestamp":1788948632,"startTime":"0","endTime":"0","summary":"Just after expressing unwavering confidence, a major shareholder cashed out. On September 9, Shu Ping, wife of HAIDILAO founder Zhang Yong, sold 259 million shares at a 6.7% discount, raking in...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1591","BK1233","BK1604","06862","BK1583","BK1589","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666581315","title":"Ming Yuan Cloud Files HKEX Next-Day Disclosure Return on Share Repurchase for Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666581315","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666581315?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:37","pubTimestamp":1788946641,"startTime":"0","endTime":"0","summary":"Ming Yuan Cloud files HKEX next-day disclosure return on share repurchase for cancellationMing Yuan Cloud filed a next-day disclosure return showing a buyback of 2,000,000 shares for cancellation.Repu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL42zNWS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1109","BK1589","BK1618","BK1117","00909","BK1583","BK1518","BK1607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175867520","title":"HAIDILAO's Controlling Shareholder Plans to Offload 259 Million Shares via Block Trade","url":"https://stock-news.laohu8.com/highlight/detail?id=1175867520","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175867520?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:26","pubTimestamp":1788945978,"startTime":"0","endTime":"0","summary":"HAIDILAO (06862) has announced that its controlling shareholder, SP NP Ltd., a member of the shareholder group, disposed of 259 million shares through a block trade at a price of HK$10.62 per share...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1583","BK1233","06862","LU2488822045.USD","BK1604","BK1591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666589669","title":"Haidilao Controlling Shareholder S&P NP Sells 259,000,000 Shares in Hk$10.62 Block Trade, Stake Falls to 45.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666589669","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666589669?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:19","pubTimestamp":1788945545,"startTime":"0","endTime":"0","summary":"Haidilao controlling shareholder SP NP sells 259,000,000 shares in HK$10.62 block trade, stake falls to 45.49%Controlling shareholder SP NP Ltd. sold 259,000,000 Haidilao shares via block trade on Sep","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL5SFKgW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1591","BK1589","06862","LU2488822045.USD","BK1233","BK1583","BK1604"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":2,"totalSize":428,"code":"91000000","status":"200"}]}}